Atlas Trials

A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants

Clinical trial NCT05355935 · COMPLETED

Trial details

NCT number
NCT05355935
Sponsor
Insmed Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2022-04-27
Primary completion
2022-10-07
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.